13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001583977-25-000005
Total Value
$1.33B
Positions
44
Other Managers
1
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,494,151 | $331.9M | 24.95% |
| 2 | EDGEWISE THERAPEUTICS INC | EWTX | 4,101,992 | $90.2M | 6.79% |
| 3 | BRIDGEBIO PHARMA INC | BBIO | 2,000,000 | $69.1M | 5.20% |
| 4 | ARCELLX INC | ACLX | 1,050,000 | $68.9M | 5.18% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 1,745,000 | $66.1M | 4.97% |
| 6 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,825,000 | $57.8M | 4.35% |
| 7 | JANUX THERAPEUTICS INC | JANX | 2,000,000 | $54.0M | 4.06% |
| 8 | EYEPOINT PHARMACEUTICALS INC | EYPT | 8,325,000 | $45.1M | 3.39% |
| 9 | INSMED INC | INSM | 525,000 | $40.1M | 3.01% |
| 10 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 1,059,331 | $38.2M | 2.87% |
| 11 | HELIX ACQUISITION CORP II | HLXC | 2,909,000 | $32.9M | 2.47% |
| 12 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,261,600 | $32.5M | 2.45% |
| 13 | MERUS N V | N5749R100 | 740,000 | $31.1M | 2.34% |
| 14 | RAPPORT THERAPEUTICS INC | RAPP | 2,940,921 | $29.5M | 2.22% |
| 15 | AXSOME THERAPEUTICS INC | AXSM | 250,000 | $29.2M | 2.19% |
| 16 | PHARVARIS N V | PHVS | 1,466,460 | $23.0M | 1.73% |
| 17 | GH RESEARCH PLC | GHRS | 2,009,482 | $22.2M | 1.67% |
| 18 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,350,000 | $21.1M | 1.59% |
| 19 | TARSUS PHARMACEUTICALS INC | TARS | 400,000 | $20.5M | 1.55% |
| 20 | ARS PHARMACEUTICALS INC | SPRY | 1,600,000 | $20.1M | 1.51% |
| 21 | CRINETICS PHARMACEUTICALS IN | CRNX | 600,000 | $20.1M | 1.51% |
| 22 | CG ONCOLOGY INC | CGON | 775,000 | $19.0M | 1.43% |
| 23 | CARGO THERAPEUTICS INC | 14179K101 | 3,381,277 | $13.8M | 1.03% |
| 24 | ABIVAX SA | AAVXF | 2,130,000 | $13.3M | 1.00% |
| 25 | ALUMIS INC | ALMS | 2,147,396 | $13.2M | 0.99% |
| 26 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 2,375,000 | $12.6M | 0.95% |
| 27 | AVIDITY BIOSCIENCES INC | 05370A108 | 400,000 | $11.8M | 0.89% |
| 28 | METSERA INC | 59267L107 | 400,000 | $10.9M | 0.82% |
| 29 | ENGENE HOLDINGS INC | ENGNW | 2,323,595 | $10.4M | 0.78% |
| 30 | BIOAGE LABS INC | BIOA | 2,629,529 | $9.9M | 0.74% |
| 31 | RHYTHM PHARMACEUTICALS INC | RYTM | 150,000 | $7.9M | 0.60% |
| 32 | ONKURE THERAPEUTICS INC | OKUR | 1,837,739 | $7.9M | 0.59% |
| 33 | BIOMEA FUSION INC | BMEA | 3,570,872 | $7.6M | 0.57% |
| 34 | KORRO BIO INC | KRRO | 380,303 | $6.6M | 0.50% |
| 35 | VAXCYTE INC | PCVX | 175,000 | $6.6M | 0.50% |
| 36 | AARDVARK THERAPEUTICS INC | AARD | 800,189 | $6.0M | 0.45% |
| 37 | MBX BIOSCIENCES INC | MBX | 700,000 | $5.2M | 0.39% |
| 38 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 250,000 | $5.1M | 0.38% |
| 39 | ENLIVEN THERAPEUTICS INC | ELVN | 250,000 | $4.9M | 0.37% |
| 40 | JANUX THERAPEUTICS INC | JANX | 150,000 | $4.0M | 0.30% |
| 41 | PLIANT THERAPEUTICS INC | PLRX | 3,000,000 | $4.0M | 0.30% |
| 42 | KALA BIO INC | KALA | 603,027 | $3.5M | 0.26% |
| 43 | STOKE THERAPEUTICS INC | STOK | 254,161 | $1.7M | 0.13% |
| 44 | BIOHAVEN LTD | BHVN | 10,000 | $240,400 | 0.02% |